Murine airway histology and intracellular uptake of inhaled amorphous itraconazole

International Journal of Pharmaceutics

Volumn 338, Issue 1-2, 2007, Pages 219-224

  Vaughn, Jason M ^a   Wiederhold, Nathan P ^a,b   McConville, Jason T ^a   Coalson, Jacqueline J ^b   Talbert, Robert L ^a,b   Burgess, David S ^a,b   Johnston, Keith P ^a   Williams III, Robert O ^a   Peters, Jay I ^c  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c University of Texas Health Science Center at San Antonio   (United States)

Author keywords

Aerosolized delivery; Itraconazole; Pulmonary histology

Indexed keywords

INTERLEUKIN 12; ITRACONAZOLE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IMMUNOGENICITY; LUNG LAVAGE; MASS SPECTROMETRY; MOUSE; NEBULIZATION; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; FEMALE; INFLAMMATION; INTERLEUKIN-12; ITRACONAZOLE; LUNG; MICE; MICE, INBRED ICR;

EID: 34248667006     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.02.014     Document Type: Article

References (32)

1. Allendoerfer R., Loebenberg D., Rinaldi M.G., and Graybill J.R. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis. Antimicrob. Agents Chemother. 39 (1995) 1345-1348
2. Baddley J.W., Stroud T.P., Salzman D., and Pappas P.G. Invasive mold infections in allogeneic bone marrow transplant recipients. Clin. Infect. Dis. 32 (2001) 1319-1324
3. Boots R.J., Paterson D.L., Allworth A.M., and Faoagali J.L. Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. Thorax 54 (1999) 1047-1049
4. Chiller T.M., and Stevens D.A. Treatment strategies for Aspergillus infections. Drug Resist. Updat. 3 (2000) 89-97
5. Cimolai N., Taylor G.P., Mah D., and Morrison B.J. Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol. Immunol. 36 (1992) 465-478
6. Drew R.H., Dodds Ashley E., Benjamin Jr. D.K., Duane Davis R., Palmer S.M., and Perfect J.R. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients. Transplantation 77 (2004) 232-237
7. Dubois J., Bartter T., Gryn J., and Pratter M.R. The physiologic effects of inhaled amphotericin B. Chest 108 (1995) 750-753
8. Griese M., Schams A., and Lohmeier K.P. Amphotericin B and pulmonary surfactant. Eur. J. Med. Res. 3 (1998) 383-386
9. Gubbins P.O., Gurley B.J., and Bowman J. Rapid and sensitive high performance liquid chromatographic method for the determination of itraconazole and its hydroxy-metabolite in human serum. J. Pharm. Biomed. Anal. 16 (1998) 1005-1012
10. Hoeben B.J., Burgess D.S., McConville J.T., Najvar L.K., Talbert R.L., Peters J.I., Wiederhold N.P., Frei B.L., Graybill J.R., Bocanegra R., Overhoff K.A., Sinswat P., Johnston K.P., and Williams III R.O. In vivo efficacy of aerosolized nanostructured itraconazole formulations for prevention of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 50 (2006) 1552-1554
11. Ichinose T., Nishikawa M., Takano H., Sera N., Sadakane K., Mori I., Yanagisawa R., Oda T., Tamura H., and Hiyoshi K. Pulmonary toxicity induced by intratracheal instillation of Asian yellow dust (Kosa) in mice. Environ. Toxicol. Pharmacol. 20 (2005) 48-56
12. Kapsi S.G., and Ayres J.W. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability. Int. J. Pharm. 229 (2001) 193-203
13. Koizumi T., Kubo K., Kaneki T., Hanaoka M., Hayano T., Miyahara T., Okada K., Fujimoto K., Yamamoto H., Kobayashi T., and Sekiguchi M. Pharmacokinetic evaluation of amphotericin B in lung tissue: lung lymph distribution after intravenous injection and airspace distribution after aerosolization and inhalation of amphotericin B. Antimicrob. Agents Chemother. 42 (1998) 1597-1600
14. Kontoyiannis D.P., Mantadakis E., and Samonis G. Systemic mycoses in the immunocompromised host: an update in antifungal therapy. J. Hosp. Infect. 53 (2003) 243-258
15. Lambros M.P., Bourne D.W., Abbas S.A., and Johnson D.L. Disposition of aerosolized liposomal amphotericin B. J. Pharm. Sci. 86 (1997) 1066-1069
16. Makino K., Yamamoto N., Higuchi K., Harada N., Ohshima H., and Terada H. Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres. Colloids Surf. B Biointerf. 27 (2003) 33-39
17. Marr K.A., Carter R.A., Crippa F., Wald A., and Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34 (2002) 909-917
18. McConville J.T., Overhoff K.A., Sinswat P., Vaughn J.M., Frei B.L., Burgess D.S., Talbert R.L., Peters J.I., Johnston K.P., and Williams III R.O. Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model. Pharm. Res. 23 (2006) 901-911
19. McConville J.T., Williams III R.O., Carvalho T.C., Iberg A.N., Johnston K.P., Talbert R.L., Burgess D., and Peters J.I. Design and evaluation of a restraint-free small animal inhalation dosing chamber. Drug Dev. Ind. Pharm. 31 (2005) 35-42
20. Monforte V., Roman A., Gavalda J., Lopez R., Pou L., Simo M., Aguade S., Soriano B., Bravo C., and Morell F. Nebulized amphotericin B concentration and distribution in the respiratory tract of lung-transplanted patients. Transplantation 75 (2003) 1571-1574
21. Palmer S.M., Drew R.H., Whitehouse J.D., Tapson V.F., Davis R.D., McConnell R.R., Kanj S.S., and Perfect J.R. Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. Transplantation 72 (2001) 545-548
22. Perfect J.R., Dodds Ashley E., and Drew R. Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients. Clin. Infect. Dis. 39 (2004) S207-S210
23. Philippe B., Ibrahim-Granet O., Prevost M.C., Gougerot-Pocidalo M.A., Sanchez Perez M., Van der Meeren A., and Latge J.P. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect. Immun. 71 (2003) 3034-3042
24. Repa A., Wild C., Hufnagl K., Winkler B., Bohle B., Pollak A., and Wiedermann U. Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy. Clin. Exp. Immunol. 137 (2004) 12-18
25. Rogers T.L., Hu J., Yu Z., Johnston K.P., and Williams III R.O. A novel particle engineering technology: spray-freezing into liquid. Int. J. Pharm. 242 (2002) 93-100
26. Ruijgrok E.J., Vulto A.G., and Van Etten E.W. Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats. J. Antimicrob. Chemother. 48 (2001) 89-95
27. Scholer N., Olbrich C., Tabatt K., Muller R.H., Hahn H., and Liesenfeld O. Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int. J. Pharm. 221 (2001) 57-67
28. Schwartz S., Behere G., Heniemann V., WAndt H., Schilling E., Arning M., Trittin A., Kern W.V., Boenisch O., Bosse D., Lenz K., Ludwig W.D., Hiddemann W., Seigert W., and Beyer J. Aerosolized amphotericin B inhalation is not effective prophylaxis of invasive aspergillus infections during prolonged neutropenia in patients after chemotherapy or autologous bone marrow transplantation. Evidence-based Oncol. 1 (2000) 87-88
29. Spickard III A., and Hirschmann J.V. Exogenous lipoid pneumonia. Arch. Intern. Med. 154 (1994) 686-692
30. Vaughn J.M., McConville J.T., Burgess D., Peters J.I., Johnston K.P., Talbert R.L., and Williams III R.O. Single dose and multiple dose studies of itraconazole nanoparticles. Eur. J. Pharm. Biopharm. 63 (2006) 95-102
31. Wald A., Leisenring W., van Burik J.A., and Bowden R.A. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J. Infect. Dis. 175 (1997) 1459-1466
32. Williams III R.O., and Liu J. Formulation of a protein with propellant HFA 134a for aerosol delivery. Eur. J. Pharm. Sci. 7 (1999) 137-144